Luning Yang
Overview
Explore the profile of Luning Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Y, Yang L, He J
Sci Rep
. 2024 Oct;
14(1):23535.
PMID: 39384789
The study aimed to comprehensively assess the separate and combined effects of physical activity (PA) and tea consumption on all-cause mortality and cancer-specific mortality among 21,350 participants from The National...
2.
Le N, McMann T, Yang L, Li Z, Cuomo R, Mackey T
JMIR Infodemiology
. 2024 Oct;
4:e58201.
PMID: 39357050
Background: Video games have rapidly become mainstream in recent decades, with over half of the US population involved in some form of digital gaming. However, concerns regarding the potential harms...
3.
Haupt M, Yang L, Purnat T, Mackey T
JMIR Infodemiology
. 2024 Sep;
4:e60678.
PMID: 39326035
Background: During the COVID-19 pandemic, the rapid spread of misinformation on social media created significant public health challenges. Large language models (LLMs), pretrained on extensive textual data, have shown potential...
4.
Zhang X, Liu S, Yang L, Cheng C, Wang H, Hu D, et al.
Expert Rev Respir Med
. 2024 Sep;
18(10):805-814.
PMID: 39257348
Introduction: Lymphangioleiomyomatosis (LAM) is a rare and progressive disorder that usually arises in the lung and almost exclusively affects women of childbearing age. In recent years, a number of molecules...
5.
Yang L, Liu D, Jiang S, Li H, Chen L, Wu Y, et al.
Biomed Pharmacother
. 2024 Jun;
177:116917.
PMID: 38908209
Sarcopenia is an aging-related skeletal disease characterized by decreased muscle mass, strength, and physical function, severely affecting the quality of life (QoL) of the elderly population. Sirtuin 1 (SIRT1), as...
6.
Xu W, Yang C, Cheng C, Wang Y, Hu D, Huang J, et al.
Chest
. 2023 Feb;
164(1):137-148.
PMID: 36801466
Background: Lymphangioleiomyomatosis is a progressive diffuse cystic lung disease with approximately 85% survival at 10 years. The determinants of disease progression and mortality after the introduction of sirolimus therapy and...
7.
Huang J, Xu W, Liu P, Liu Y, Shen C, Liu S, et al.
BMC Pulm Med
. 2022 Sep;
22(1):354.
PMID: 36117164
Background: Sporadic lymphangioleiomyomatosis (S-LAM) is a rare neoplasm with heterogeneous clinical features that is conventionally considered to be related to TSC2. This study serves to elucidate the mutation landscape and...
8.
Cheng C, Xu W, Wang Y, Zhang T, Yang L, Zhou W, et al.
Orphanet J Rare Dis
. 2022 Jul;
17(1):257.
PMID: 35804431
Background: Spontaneous pneumothorax has a high incidence and high rate of recurrence in patients with lymphangioleiomyomatosis (LAM). The risk factors for pneumothorax and the effects of sirolimus on pneumothorax in...
9.
Liu Z, Li X, Fan G, Zhou F, Wang Y, Huang L, et al.
Clin Microbiol Infect
. 2020 Oct;
27(1):112-117.
PMID: 33007478
Objectives: Use of corticosteroids is common in the treatment of coronavirus disease 2019, but clinical effectiveness is controversial. We aimed to investigate the association of corticosteroids therapy with clinical outcomes...
10.
Xu J, Huang C, Fan G, Liu Z, Shang L, Zhou F, et al.
Front Med
. 2020 Jul;
14(5):601-612.
PMID: 32621202
The possible effects of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) on COVID-19 disease severity have generated considerable debate. We performed a single-center, retrospective analysis of hospitalized...